跳至主要内容
临床试验/NCT06933875
NCT06933875招募中不适用

Promoting Palliative Care for People With Heart Failure: The P3HF Pilot Study

Yale University2 个研究点 分布在 1 个国家目标入组 2,260 人开始时间: 2026年7月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
2,260
试验地点
2
主要终点
Mean System Usability Scale score

研究概览

简要总结

This project will develop and test a novel clinical decision support tool (CDS) that encourages timely referral to palliative care for people hospitalized with heart failure. This intervention will incorporate an existing, validated 1-year mortality risk model into a CDS to deliver prognostic information and evidence-based decision support at the point of care. Thus, this research may lead to improved care-concordant and goal-directed care for people with heart failure.

详细描述

Healthcare providers will encounter the tool during the routine care of their hospitalized patients. Patients randomized to the intervention arm will have providers who receive the tool and can complete one post-trial survey. High use providers will also have the opportunity to participate in a survey and 1 post-trial interview. Level 2 providers will participate in one interview.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Healthcare providers must meet the following criteria:
  • •Are an attending physician, fellow, or resident, advanced practice nurse, or physician associate
  • •Has ordering privileges
  • •Are members of one of the hospitals' admitting teams (e.g., hospitalist service, cardiology service)
  • •Anticipate employment at one of the two study sites for the 15-month trial period.
  • •Palliative care team member
  • •Hospital administrator/quality and safety personnel
  • •Patients of providers enrolled in the study must meet the following criteria for heart failure during hospitalization:
  • •Age 18 years of age or older
  • •N-terminal pro-B-type natriuretic peptide values of >500 pg/ml
  • •Received intravenous diuretics within 24 hours of admission.

排除标准

  • •Pregnant at the time of admission.

研究组 & 干预措施

Clinical Decision Support (CDS) Tool

Experimental

Patients will be randomized to have the CDS tool to deliver prognostic information and evidence-based decision support at the point of care for timely referral to palliative care for participants hospitalized with heart failure.

干预措施: Clinical Decision Support Tool (Behavioral)

Standard of Care

No Intervention

Providers will provide usual standard of care for participants hospitalized with heart failure.

结局指标

主要结局

Mean System Usability Scale score

时间窗: up to 15 months

System Usability Scale, 10-item Likert questionnaire. Total score range 0-100. Higher values indicate higher usability

Mean Acceptability of Intervention Measure score

时间窗: up to 15 months

Acceptability of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher acceptability.

Mean Appropriateness of Intervention Measure score

时间窗: up to 15 months

Appropriateness of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher appropriateness.

Mean Feasibility of Intervention Measure score

时间窗: up to 15 months

Feasibility of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher feasibility.

次要结局

  • Change in Code Status(up to 15 months)
  • Referral to Specialist Palliative Care(up to 15 months)
  • Consultation by Specialist Palliative Care(up to 15 months)
  • Advance Care Plan Documentation(up to 15 months)
  • Participants enrolled in hospice(up to 15 months)
  • Mean hospital length of stay(up to 15 months)
  • Participants readmitted to hospital(up to 15 months)

研究者

发起方
Yale University
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验